FR1519M - Médicament destiné au traitement de certaines affections neuro-psychiques. - Google Patents

Médicament destiné au traitement de certaines affections neuro-psychiques.

Info

Publication number
FR1519M
FR1519M FR874708A FR874708A FR1519M FR 1519 M FR1519 M FR 1519M FR 874708 A FR874708 A FR 874708A FR 874708 A FR874708 A FR 874708A FR 1519 M FR1519 M FR 1519M
Authority
FR
France
Prior art keywords
affections
psychic
treatment
drug intended
neuro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR874708A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GERDA LAB
Original Assignee
GERDA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GERDA LAB filed Critical GERDA LAB
Priority to FR874708A priority Critical patent/FR1519M/fr
Application granted granted Critical
Publication of FR1519M publication Critical patent/FR1519M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR874708A 1961-10-02 1961-10-02 Médicament destiné au traitement de certaines affections neuro-psychiques. Expired FR1519M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR874708A FR1519M (fr) 1961-10-02 1961-10-02 Médicament destiné au traitement de certaines affections neuro-psychiques.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR874708A FR1519M (fr) 1961-10-02 1961-10-02 Médicament destiné au traitement de certaines affections neuro-psychiques.

Publications (1)

Publication Number Publication Date
FR1519M true FR1519M (fr) 1962-10-08

Family

ID=87760740

Family Applications (1)

Application Number Title Priority Date Filing Date
FR874708A Expired FR1519M (fr) 1961-10-02 1961-10-02 Médicament destiné au traitement de certaines affections neuro-psychiques.

Country Status (1)

Country Link
FR (1) FR1519M (fr)

Similar Documents

Publication Publication Date Title
FR1514M (fr) Nouvelles préparations thérapeutiques.
FR2489M (fr) Médicament pour le traitement de la dysenterie amibienne.
FR1056M (fr) Produit pharmaceutiqué destine au traitement des affections circulatoires des membres supérieurs ou inférieurs.
FR1137M (fr) Applications thérapeutiques de cyclohexyl-phénols.
FR1519M (fr) Médicament destiné au traitement de certaines affections neuro-psychiques.
FR3875M (fr) Nouveau médicament convenant notamment au traitement des infections tuberculeuses.
FR1306M (fr) Nouveau médicament destiné au traitement des affections bucco-dentaires.
FR15F (fr) Produit pharmaceutique destiné au traitement des affections ?culatoires des membres supérieurs et inférieurs.
FR3500M (fr) Nouveau médicament destiné au traitement des rhinites.
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
BE598672A (fr) Composition thérapeutique pour le traitement des affections hépatiques.
FR2510M (fr) Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
FR1317M (fr) Nouveau médicament convenant notamment au traitement des affections intestinales.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR1037M (fr) Médicament destiné au traitement des aérocolies, du météorisme et des gastralgies.
FR1224M (fr) Traitement homéoflore des glandes sébacées.
FR1230M (fr) Traitement homéoflore de la grippe.
FR1961M (fr) Compositions pour le traitement de la toxicomanie.
BE630069A (fr) Composition thérapeutique pour le traitement du parkinsonisme.
FR3744M (fr) Médicaments pour le traitement des affections psychiatriques.
FR1231M (fr) Traitement homéoflore de la sinusite et des infections dentaires.
GR22278B (el) Μεθοδος παρασκευης φαρμακου δια την θεραπειαν τουκαρκινου.
FR2786M (fr) Médicament pour le traitement des maladies cardiaques.
FR222F (fr) Nouveau médicament destiné au traitement des affections bucco-dentaires
FR2817M (fr) Associations de médicaments pour le traitement des désordres mentaux.